Stefano Brillanti

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Hepatitis C Virus

Patient Reported Outcomes

Top Venues

Journal of clinical medicine

Life (Basel, Switzerland)

European radiology

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Stasi, Stefano Brillanti
Liver Stiffness Evaluation in Chronic Hepatitis C Patients with Cirrhosis before and after Direct-Acting Antivirals. Microorganisms 12 (7) (2024)
Cristina Stasi, Stefano Brillanti
Liver Stiffness Evaluation in Chronic Hepatitis C Patients with Cirrhosis before and after Direct-Acting Antivirals. Microorganisms 12 (7) (2024)
Cristina Stasi, Stefano Brillanti
Liver Stiffness Values to Predict Occurrence and Recurrence of Hepatocellular Carcinoma. Life (Basel, Switzerland) 14 (3) (2024)
Cristina Stasi, Stefano Brillanti
Liver Stiffness Evaluation in Chronic Hepatitis C Patients with Cirrhosis before and after Direct-Acting Antivirals. Microorganisms 12 (7) (2024)
Cristina Stasi, Stefano Brillanti
Liver Stiffness Values to Predict Occurrence and Recurrence of Hepatocellular Carcinoma. Life (Basel, Switzerland) 14 (3) (2024)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Stefano Brillanti
Management of Delta Hepatitis 45 Years after the Discovery of HDV. Journal of clinical medicine 11 (6) (2022)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Leonardo Frazzoni, Usama Sikandar, Giuseppe Mazzella, Lorenzo Fuccio, Franco Bazzoli, Stefano Brillanti, Francesco Azzaroli
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy. Journal of viral hepatitis 28 (5) (2021)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Matteo Renzulli, Federica Buonfiglioli, Fabio Conti, Stefano Brocchi, Ilaria Serio, Francesco Giuseppe Foschi, Paolo Caraceni, Giuseppe Mazzella, Gabriella Verucchi, Rita Golfieri, Pietro Andreone, Stefano Brillanti
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis. European radiology 28 (2) (2017)